Ascendis Pharma A/S Announces Upcoming Investor Presentations
(WorldNews Denmark)

COPENHAGEN, Denmark, April 28, 2017 /PRNewswire/ -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will participate in two upcoming investor conferences in May. Jan Mikkelsen, President and CEO at Ascendis, will provide a business overview and update on the company`s three rare disease endocrinology pipeline programs. Details include: Event Deutsche Bank 42 Annual Health Care Conference Location Boston, MA Date Wednesday, May 3 Time 1:30 p.m. Eastern Time Event Bank of America Merrill Lynch 2017 Healthcare Conference Location Las...